Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

Characterization of the Genotypic Profile of Hepatitis Delta Virus: Isolation of HDV Genotype-1 in the Western Amazon Region of Brazil.

Botelho-Souza LF, Souza Vieira D, de Oliveira Dos Santos A, Cunha Pereira AV, Villalobos-Salcedo JM.

Intervirology. 2015;58(3):166-71. doi: 10.1159/000431040. Epub 2015 Jun 19.

2.

Infectious long non-coding RNAs.

Katsarou K, Rao AL, Tsagris M, Kalantidis K.

Biochimie. 2015 Oct;117:37-47. doi: 10.1016/j.biochi.2015.05.005. Epub 2015 May 15. Review.

PMID:
25986218
3.

Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.

He W, Ren B, Mao F, Jing Z, Li Y, Liu Y, Peng B, Yan H, Qi Y, Sun Y, Guo JT, Sui J, Wang F, Li W.

PLoS Pathog. 2015 Apr 22;11(4):e1004840. doi: 10.1371/journal.ppat.1004840. eCollection 2015 Apr.

4.

Hepatitis Delta co-infection in humanized mice leads to pronounced induction of innate immune responses in comparison to HBV mono-infection.

Giersch K, Allweiss L, Volz T, Helbig M, Bierwolf J, Lohse AW, Pollok JM, Petersen J, Dandri M, Lütgehetmann M.

J Hepatol. 2015 Aug;63(2):346-53. doi: 10.1016/j.jhep.2015.03.011. Epub 2015 Mar 17.

PMID:
25795587
5.

HDVDB: a data warehouse for hepatitis delta virus.

Singh S, Gupta SK, Nischal A, Pant KK, Seth PK.

Int J Bioinform Res Appl. 2015;11(2):162-70. doi: 10.1504/IJBRA.2015.068091.

PMID:
25786795
6.

Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression.

Shirvani-Dastgerdi E, Amini-Bavil-Olyaee S, Alavian SM, Trautwein C, Tacke F.

Clin Microbiol Infect. 2015 May;21(5):510.e11-23. doi: 10.1016/j.cmi.2014.12.008. Epub 2014 Dec 26.

7.

Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).

Veloso Alves Pereira I, Buchmann B, Sandmann L, Sprinzl K, Schlaphoff V, Döhner K, Vondran F, Sarrazin C, Manns MP, Pinto Marques Souza de Oliveira C, Sodeik B, Ciesek S, von Hahn T.

PLoS One. 2015 Feb 3;10(2):e0117152. doi: 10.1371/journal.pone.0117152. eCollection 2015.

8.

Protein-peptide arrays for detection of specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among HDV-infected patients by surface plasmon resonance imaging.

Villiers MB, Cortay JC, Cortès S, Bloquel B, Brichler S, Brakha C, Kay A, Falah N, Zoulim F, Marquette C, Marche PN, Dény P.

J Clin Microbiol. 2015 Apr;53(4):1164-71. doi: 10.1128/JCM.03002-14. Epub 2015 Jan 28.

9.

Detection of hepatitis D virus RNA carrying large fragment deletions in patients with severe hepatitis B/D receiving oral antiviral therapy.

Hsu CW, Chao M, Chen YC, Chang ML, Huang SF, Yeh CT.

J Med Virol. 2015 Apr;87(4):634-41. doi: 10.1002/jmv.24107. Epub 2015 Jan 21.

PMID:
25612072
10.

Epidemiological, clinical and histological characteristics of HBV/HDV co-infection: a retrospective cross-sectional study in Guangdong, China.

Liao B, Zhang F, Lin S, He H, Liu Y, Zhang J, Xu Y, Yi J, Chen Y, Liu H, Wang Z, Cai W.

PLoS One. 2014 Dec 22;9(12):e115888. doi: 10.1371/journal.pone.0115888. eCollection 2014.

11.

The role of an active site Mg(2+) in HDV ribozyme self-cleavage: insights from QM/MM calculations.

Mlýnský V, Walter NG, Šponer J, Otyepka M, Banáš P.

Phys Chem Chem Phys. 2015 Jan 7;17(1):670-9. doi: 10.1039/c4cp03857f.

12.

Hepatitis D virus coinfection and superinfection.

Negro F.

Cold Spring Harb Perspect Med. 2014 Nov 3;4(11):a021550. doi: 10.1101/cshperspect.a021550. Review.

13.

Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.

Huang CR, Lo SJ.

World J Gastroenterol. 2014 Oct 28;20(40):14589-97. doi: 10.3748/wjg.v20.i40.14589.

14.

Can antiretroviral therapy modify the clinical course of HDV infection in HIV-positive patients?

Onali S, Figorilli F, Balestrieri C, Serra G, Conti M, Scioscia R, Barca L, Lai ME, Chessa L.

Antivir Ther. 2015;20(7):671-9. doi: 10.3851/IMP2911. Epub 2014 Oct 27.

PMID:
25345373
15.

Rapid hepatitis B and hepatitis Delta virus RNA quantification from small-sized liver tissue samples.

Taranta A, Rogalska-Taranta M, Gutierrez R, Manns MP, Bock M, Wursthorn K.

J Clin Virol. 2014 Oct;61(2):286-8. doi: 10.1016/j.jcv.2014.07.016. Epub 2014 Aug 2. No abstract available.

PMID:
25151628
16.

Analysis on the clinical features of 507 HDV-infected patients.

Gu XH, Chen Z, Dai RY, Zhang ML, Tang HM, Chen LB, Dong B.

Cell Biochem Biophys. 2014 Dec;70(3):1829-32. doi: 10.1007/s12013-014-0137-8.

PMID:
25085619
17.

The efficacy of the Peginterferon treatment in chronic hepatitis HDV and compensate liver cirrhosis.

Tugui L, Dumitru M, Iacob S, Gheorghe L, Preda C, Dinu I, Becheanu G, Dumbrava M, Nicolae I, Andrei A, Lupu A, Diculescu M.

Rev Med Chir Soc Med Nat Iasi. 2014 Apr-Jun;118(2):368-75.

PMID:
25076702
18.

Anti-HDV IgM as a marker of disease activity in hepatitis delta.

Wranke A, Heidrich B, Ernst S, Calle Serrano B, Caruntu FA, Curescu MG, Yalcin K, Gürel S, Zeuzem S, Erhardt A, Lüth S, Papatheodoridis GV, Bremer B, Stift J, Grabowski J, Kirschner J, Port K, Cornberg M, Falk CS, Dienes HP, Hardtke S, Manns MP, Yurdaydin C, Wedemeyer H; HIDIT-2 Study Group.

PLoS One. 2014 Jul 29;9(7):e101002. doi: 10.1371/journal.pone.0101002. eCollection 2014.

19.

Free circulating nucleic acids in plasma and serum as a novel approach to the use of internal controls in real time PCR based detection.

Karataylı E, Altunoğlu YÇ, Karataylı SC, Yurdaydın C, Bozdayı AM.

J Virol Methods. 2014 Oct;207:133-7. doi: 10.1016/j.jviromet.2014.07.008. Epub 2014 Jul 14.

PMID:
25034126
20.

Relevance of a full-length genomic RNA standard and a thermal-shock step for optimal hepatitis delta virus quantification.

Homs M, Giersch K, Blasi M, Lütgehetmann M, Buti M, Esteban R, Dandri M, Rodriguez-Frias F.

J Clin Microbiol. 2014 Sep;52(9):3334-8. doi: 10.1128/JCM.00940-14. Epub 2014 Jul 2.

Supplemental Content

Loading ...
Support Center